Leveraging AI to Accelerate India’s Digital Biology and Health Ecosystem
, Director, Digital Biology, NVIDIA
, Cofounder and Group Chief Technical Officer, Innoplexus
, Domain Delivery Head of Clinical and Medical Services, Tata Consultancy Services
, Director, Clinical Programming & Insights – Data Management,CDI, AstraZeneca
This panel will explore the unique ways that AI and accelerated computing can advance and grow both well-established and emerging segments of the Indian biopharma ecosystem. Senior leaders will discuss AI's impact on established strengths, like contract development and manufacturing, and its potential to accelerate nascent efforts, including early drug discovery and development. The discussion will cover practical AI integration today and future workflows, highlighting India's growth in pharma services, robust R&D efforts, and the evolving life sciences ecosystem. We will place special emphasis on the clinical relevance of success here, providing insights into AI's transformative role in the end-to-end drug discovery to delivery market.